3D66
Crystal structure of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID29 |
Synchrotron site | ESRF |
Beamline | ID29 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2007-03-10 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 1.26206 |
Spacegroup name | P 31 2 1 |
Unit cell lengths | 161.740, 161.740, 139.450 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 49.510 - 3.100 |
R-factor | 0.20621 |
Rwork | 0.204 |
R-free | 0.24038 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1kwm |
RMSD bond length | 0.018 |
RMSD bond angle | 1.751 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.510 | 3.270 |
High resolution limit [Å] | 3.100 | 3.100 |
Rmerge | 0.105 | 0.833 |
Number of reflections | 38593 | |
<I/σ(I)> | 13.9 | 2.6 |
Completeness [%] | 100.0 | 100 |
Redundancy | 8.6 | 8.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 6 | 277 | 16-18% PEG 3000, 0.18-0.22mM Na/K-tartrate, 50mM L-glutamate, 50 mM L-arginine, pH 6.0, VAPOR DIFFUSION, temperature 277K |